ArticleEuropean journal of pediatrics2025
Diagnosis of patent ductus arteriosus by different echocardiographic methods in very preterm infants.
Article in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Active treatment vs. expectant management of patent ductus arteriosus in preterm infants: critical analysis of a meta-analysis.Italian journal of pediatrics · 2026Article
- Comparison of Ventilation Support During Laser Treatment of Retinopathy of Prematurity.Children (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is no consensus regarding the timing and diagnostic criteria for identifying hemodynamically significant patent ductus arteriosus (hsPDA). Our aim was to evaluate if the use of different diagnostic criteria at different times could be associated with a different incidence of hsPDA in very preterm infants. We studied 41 infants with gestational age < 32 weeks born in neonatal intensive care units (NICU) in Florence, Italy, or in Paris, France. They received the first echocardiography between 24 and 48 h of life and the second between 72 and 84 h to diagnose hsPDA using Florence and Paris criteria and PDA severity score. Concordance of diagnosis between criteria was evaluated with the Cohen unweighted κ statistic. The incidence of hsPDA diagnosed by the Florence (35%) or Paris (34%) criteria or by PDA severity score (35%) was similar. Concordance was substantial between Florence and Paris criteria and between Florence criteria and PDA severity score but was fair between Paris criteria and PDA severity score. Moreover, concordance significantly changed from the first to the second echocardiography. Conclusion: The studied diagnostic criteria showed important variations of concordance when applied at different times. This led to diagnose hsPDA in different patients at different times while leaving the overall percentage of hsPDA unchanged. Our results suggest that more attention should be paid to the choice of diagnostic criteria for individuating hsPDA in very preterm infants. What is Known: • There is no consensus regarding the timing and diagnostic criteria for individuating hemodynamically significant patent ductus arteriosus (hsPDA) in preterm infant. • This implies large variations in its frequency and management diagnosis between centers. What is New: • This study evaluated for the first time how different diagnostic criteria used at different postnatal times may influence the diagnosis of hsPDA in very preterm infants.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.